Sort by: after hours % change | delayed % change | gain open | gain high | gain close | publishing date
tags : Treatment source : Www.vbivaccines.com save search
VBI Vaccines Partner Brii Biosciences Announces Topline Interim Results of Phase 2 Study Evaluating BRII-179 (VBI-2601) in Combination With PEG-IFNα for the Treatment of Chronic Hepatitis B
Published: 2023-09-06 (Crawled : 12:00) - vbivaccines.com
CYDY | $0.1501 0.06% 790K
|
Manufacturing
|
| O: 0.49%
H: 1.94%
C: 1.94%
JNJ | News | $149.56 0.3% 0.0% 9.1M
|
Health Technology
|
| O: -0.37%
H: 0.0%
C: 0.0%
VBIV | $0.591 -1.99% -2.03% 110K
|
Health Technology
|
| O: 0.81%
H: 0.8%
C: -2.4%
TRIB | $1.81 -3.87% 2.8K
|
Health Technology
|
| O: -0.38%
H: 1.87%
C: 1.86%
SNY | News | $47.69 1.15% 1.13% 1.7M
|
Health Technology
|
| O: -0.83%
H: 0.19%
C: -0.09%
RGEN | $171.3 8.78% 8.07% 930K
|
Health Technology
|
| O: -0.47%
H: 0.45%
C: -0.51%
IMGN | News | $31.23 0.03% 49M
|
Health Technology
|
| O: -1.56%
H: 0.0%
C: 0.0%
AVID | $27.04 0.07% 630K
|
Technology Services
|
| O: 0.26%
H: 0.37%
C: 0.26%
brii-179 hepatitis treatment topline results study
VBI Vaccines Granted FDA Fast Track Designation for VBI-1901 for the Treatment of Recurrent GBM
Published: 2021-06-08 (Crawled : 12:00) - vbivaccines.com
VBIV | $0.591 -1.99% -2.03% 110K
|
Health Technology
|
| O: 4.62%
H: 9.67%
C: 9.39%
AGEN A | $6.44 11.61% 10.4% 1.7M
|
Health Technology
|
| O: 1.87%
H: 14.68%
C: 14.45%
treatment fda fda fast track fast track vaccine fast track designation granted grant designation
Brii Biosciences, Vir Biotechnology, and VBI Vaccines Announce Initiation of Phase 2 Clinical Trial of BRII-835 (VIR-2218) in Combination with BRII-179 (VBI-2601) for the Treatment of Hepatitis B
Published: 2021-04-21 (Crawled : 12:00) - vbivaccines.com
VIR | $8.13 0.37% 0.37% 770K
|
Health Technology
|
| O: -1.09%
H: 0.38%
C: 0.04%
VBIV | $0.591 -1.99% -2.03% 110K
|
Health Technology
|
| O: 0.0%
H: 7.66%
C: 7.66%
ALNY | $146.06 0.19% 0.18% 540K
|
Health Technology
|
| O: 0.67%
H: 1.12%
C: 0.43%
treatment phase 2 hepatitis vbi-2601 biotech vaccine technology iot brii-835 trial
Gainers vs Losers
| 78% | 22% |
Top 10 Gainers
MTTR | News 4 | $4.6 164.37% 62.17% 28M
|
AGBA | $2.94 135.2% 57.48% 66M
|
Finance
EDBL | News | $6.46 71.81% 41.8% 2M
|
MTC | $2.25 44.23% 30.67% 6M
|
Technology Services
OPRT | News | $3.175 41.11% 29.13% 12M
|
Finance
SHIM | $3.05 35.56% 26.23% 1.1M
|
HKIT | $1.345 31.86% 24.16% 390K
|
Technology Services
ABVC | $1.36 30.77% 23.53% 7.4M
|
Wholesale Trade
OST | $0.512 28.0% 21.88% 290K
|
POET | $1.59 27.2% 21.38% 4.2M
|
Manufacturing
Your saved searches
Save your searches and get alerts when important news are released.